TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
TwinStrand Biosciences has raised $10.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.
TwinStrand Biosciences's investors include Madrona, S32, Soleus Capital, Janus Henderson Investors, Alexandria Venture Investments.
TwinStrand Biosciences is headquartered in Seattle, United States.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
TwinStrand Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TwinStrand Biosciences — Funding & Investors." VCBacked, June 30, 2023, https://www.vcbacked.co/company/twinstrand-biosciences. Accessed November 14, 2026.
VCBacked. (2023). TwinStrand Biosciences — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/twinstrand-biosciences
{{cite web |title=TwinStrand Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/twinstrand-biosciences |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at TwinStrand Biosciences? Request a listing update